﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/piramal-pharma-solutions-boosts-formulation-development-at-morpeth-site-with-korsch-xm-12-17838</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/roche-secures-ce-mark-for-accu-chek-smartguide-cgm-with-mysugr-app-integration-17839</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/ascletis-reports-positive-phase-ib-results-for-oral-glp-1r-agonist-asc30-at-easd-2025-17840</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/allrock-bio-raises-50-million-to-drive-therapy-for-pulmonary-hypertension-into-phase-2-trials-17841</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/curateq-biologics-completes-phase-3-clinical-study-for-denosumab-biosimilar-17842</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sai-life-sciences-opens-dedicated-facility-for-veterinary-apis-in-bidar-17843</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/merck-opens-150-million-manufacturing-facility-in-ireland-17844</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-completes-inspection-of-indocos-api-manufacturing-facility-at-patalganga-with-zero-observations-17845</loc><lastmod>2025-09-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>